`ESTTA966227
`04/11/2019
`
`ESTTA Tracking number:
`
`Filing date:
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`Applicants
`
`Application Serial Number
`
`Application Filing Date
`
`Mark
`
`Date of Publication
`
`Potential Opposer's
`Correspondence Information
`
`Boehringer Ingelheim Vetmedica GmbH
`
`79238258
`
`06/13/2018
`
`ZIVUMAR
`
`12/18/2018
`
`Tiffany A. Blofield
`Winthrop & Weinstine P.A.
`225 South Sixth Street
`Suite 3500
`Minneapolis, MN 55402
`UNITED STATES
`Tblofield@winthrop.com, Sbaird@winthrop.com,
`Trademark@winthrop.com,
`Cclassen@winthrop.com,
`Ayoung@winthrop.com, Greyes@winthrop.com
`612-604-6684
`
`60 Day Request for Extension of Time to Oppose Upon Consent
`
`Pursuant to 37 C.F.R. Section 2.102, JAZZ PHARMACEUTICALS, INC., 3170 Porter Drive, Palo Alto, CA
`94304, UNITED STATES respectfully requests that he/she/it be granted an additional 60-day extension of
`time to file a notice of opposition against the above-identified mark with applicant's consent.
`The time within which to file a notice of opposition is set to expire on 04/17/2019. JAZZ PHARMACEUTIC-
`ALS, INC. respectfully requests that the time period within which to file an opposition be extended until
`06/16/2019.
`Respectfully submitted,
`/Tiffany A. Blofield/
`Tiffany A. Blofield
`Tblofield@winthrop.com, Sbaird@winthrop.com, Trademark@winthrop.com, Cclassen@winthrop.com,
`Ayoung@winthrop.com, Greyes@winthrop.com
`04/11/2019
`
`



